ArticleJournal of neuroengineering and rehabilitation2026
Predicting prosthesis use and mobility needs in lower limb amputees: a machine learning approach using clinical and actigraphy data.
Article in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03930199 (Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundDespite advances in prosthetic technology, many individuals with lower limb amputation (LLA) fall short of achieving their full functional potential. The Medicare Functional Classification Level (K-level) system remains a standard for guiding prosthetic prescriptions; however, it has historically reflected anticipated mobility potential rather than actual performance in daily life. Similarly, standardized clinical assessments provide only episodic snapshots and are limited in their ability to determine whether individuals will meet their real-world mobility goals. Consequently, there is a pressing need for objective, scalable methods to capture prosthesis use and activity in the community.
objectiveThis study investigated the potential of machine learning (ML) and passively collected community activity data to predict two key outcomes in prosthetic users: (1) reassessed K-level based on real-world mobility data and expert panel review, and (2) attainment of self-defined mobility goals.
methodsFifty-three adults with unilateral or bilateral LLA participated in three months of passive community monitoring using ActiGraph accelerometers. Participants also completed standardized performance-based, patient-reported outcome measures, and a semi-structured mobility goal interview. A multidisciplinary expert panel reviewed all data to reassess the K-level and review whether participants met their personal mobility goals. These served as ground truth for model evaluation. Gradient-boosted classifiers were trained using combinations of demographic, performance-based, patient-reported, and sensor-derived (ActiGraph) features across various community monitoring durations (3, 7, 30, and ≥ 90 days).
resultsModels predicting reassessed K-levels demonstrated modest recall (range: 30.6–60.4%), with the best performance (60.4%) achieved using demographic, performance-based, patient-reported and 30 days of community ActiGraph data. Longer monitoring durations (≥ 90 days) reduced performance. In contrast, models predicting personal goal attainment achieved consistently high recall (Range: 77.0–89.9%), with the best-performing model using demographic, performance-based, patient-reported, and ActiGraph data. Notably, removing the performance-based outcomes had minimal impact (recall ≥ 82.1% with just 3 days of monitoring).
conclusionsML models predicting personal goal attainment outperformed those targeting K-level classification, particularly when using passively collected community activity data. These findings support the value of real-world passive sensing as scalable, low-burden strategy to remotely identify individuals at risk of suboptimal outcomes and enable timely, goal-oriented rehabilitation. Trial registration This work includes data from a registered clinical trial (NCT03930199).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.